213 related articles for article (PubMed ID: 17250993)
1. Increased serum levels of a proliferation-inducing ligand in patients with bullous pemphigoid.
Watanabe R; Fujimoto M; Yazawa N; Nakashima H; Asashima N; Kuwano Y; Tada Y; Maruyama N; Okochi H; Tamaki K
J Dermatol Sci; 2007 Apr; 46(1):53-60. PubMed ID: 17250993
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of BAFF are increased in bullous pemphigoid but not in pemphigus vulgaris.
Asashima N; Fujimoto M; Watanabe R; Nakashima H; Yazawa N; Okochi H; Tamaki K
Br J Dermatol; 2006 Aug; 155(2):330-6. PubMed ID: 16882171
[TBL] [Abstract][Full Text] [Related]
3. Increased serum levels of circulating CD40 ligand in patients with bullous pemphigoid: preliminary results.
Watanabe R; Ishiura N; Nakashima H; Yazawa N; Kuwano Y; Tada Y; Okochi H; Fujimoto M; Tamaki K
Dermatology; 2007; 215(3):180-6. PubMed ID: 17823512
[TBL] [Abstract][Full Text] [Related]
4. Elevated serum levels of APRIL, but not BAFF, in patients with atopic dermatitis.
Matsushita T; Fujimoto M; Echigo T; Matsushita Y; Shimada Y; Hasegawa M; Takehara K; Sato S
Exp Dermatol; 2008 Mar; 17(3):197-202. PubMed ID: 17979975
[TBL] [Abstract][Full Text] [Related]
5. Elevated serum APRIL levels in patients with systemic sclerosis: distinct profiles of systemic sclerosis categorized by APRIL and BAFF.
Matsushita T; Fujimoto M; Hasegawa M; Tanaka C; Kumada S; Ogawa F; Takehara K; Sato S
J Rheumatol; 2007 Oct; 34(10):2056-62. PubMed ID: 17896803
[TBL] [Abstract][Full Text] [Related]
6. Serum BAFF predicts prognosis better than APRIL in diffuse large B-cell lymphoma patients treated with rituximab plus CHOP chemotherapy.
Kim SJ; Lee SJ; Choi IY; Park Y; Choi CW; Kim IS; Yu W; Hwang HS; Kim BS
Eur J Haematol; 2008 Sep; 81(3):177-84. PubMed ID: 18510703
[TBL] [Abstract][Full Text] [Related]
7. Serum BAFF and APRIL levels in patients with PBC.
Migita K; Ilyassova B; Kovzel EF; Nersesov A; Abiru S; Maeda Y; Komori A; Ito M; Yano K; Yatsuhashi H; Shimoda S; Ishibashi H; Nakamura M
Clin Immunol; 2010 Feb; 134(2):217-25. PubMed ID: 19840904
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of tumour necrosis factor family members a proliferation-inducing ligand (APRIL) and B lymphocyte stimulator (BLyS) are inversely correlated in systemic lupus erythematosus.
Morel J; Roubille C; Planelles L; Rocha C; Fernandez L; Lukas C; Hahne M; Combe B
Ann Rheum Dis; 2009 Jun; 68(6):997-1002. PubMed ID: 18676986
[TBL] [Abstract][Full Text] [Related]
9. Bullous pemphigoid and pemphigus vulgaris: correlated behaviour of serum VEGF, sE-selectin and TNF-alpha levels.
Ameglio F; D'Auria L; Cordiali-Fei P; Mussi A; Valenzano L; D'Agosto G; Ferraro C; Bonifati C; Giacalone B
J Biol Regul Homeost Agents; 1997; 11(4):148-53. PubMed ID: 9582615
[TBL] [Abstract][Full Text] [Related]
10. Differential effects on BAFF and APRIL levels in rituximab-treated patients with systemic lupus erythematosus and rheumatoid arthritis.
Vallerskog T; Heimbürger M; Gunnarsson I; Zhou W; Wahren-Herlenius M; Trollmo C; Malmström V
Arthritis Res Ther; 2006; 8(6):R167. PubMed ID: 17092341
[TBL] [Abstract][Full Text] [Related]
11. Association of serum B cell activating factor from the tumour necrosis factor family (BAFF) and a proliferation-inducing ligand (APRIL) with central nervous system and renal disease in systemic lupus erythematosus.
Vincent FB; Northcott M; Hoi A; Mackay F; Morand EF
Lupus; 2013 Aug; 22(9):873-84. PubMed ID: 23846230
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid levels of a proliferation-inducing ligand (APRIL) are increased in patients with neuropsychiatric systemic lupus erythematosus.
Hopia L; Thangarajh M; Khademi M; Laveskog A; Wallström E; Svenungsson E; Andersson M
Scand J Rheumatol; 2011; 40(5):363-72. PubMed ID: 21585290
[TBL] [Abstract][Full Text] [Related]
13. Serum BAFF and APRIL might be associated with disease activity and kidney damage in patients with anti-glomerular basement membrane disease.
Xin G; Cui Z; Su Y; Xu LX; Zhao MH; Li KS
Nephrology (Carlton); 2013 Mar; 18(3):209-14. PubMed ID: 23317407
[TBL] [Abstract][Full Text] [Related]
14. Presence of interleukin 10 in the serum and blister fluid of patients with pemphigus vulgaris and pemphigoid.
Bhol KC; Rojas AI; Khan IU; Ahmed AR
Cytokine; 2000 Jul; 12(7):1076-83. PubMed ID: 10880254
[TBL] [Abstract][Full Text] [Related]
15. Age-related changes in BAFF and APRIL profiles and upregulation of BAFF and APRIL expression in patients with primary antibody deficiency.
Jin R; Kaneko H; Suzuki H; Arai T; Teramoto T; Fukao T; Kondo N
Int J Mol Med; 2008 Feb; 21(2):233-8. PubMed ID: 18204790
[TBL] [Abstract][Full Text] [Related]
16. B-lymphocyte stimulator and a proliferation-inducing ligand serum levels in IgA-deficient patients with and without celiac disease.
Fabris M; De Vita S; Visentini D; Fabro C; Picierno A; Lerussi A; Villalta D; Alessio MG; Tampoia M; Tonutti E
Ann N Y Acad Sci; 2009 Sep; 1173():268-73. PubMed ID: 19758161
[TBL] [Abstract][Full Text] [Related]
17. Elevated expression of CD23 on peripheral blood B lymphocytes from patients with bullous pemphigoid: correlation with increased serum IgE.
Inaoki M; Sato S; Takehara K
J Dermatol Sci; 2004 Jun; 35(1):53-9. PubMed ID: 15194147
[TBL] [Abstract][Full Text] [Related]
18. Role of BP180NC16a-enzyme-linked immunosorbent assay (ELISA) in the diagnosis of bullous pemphigoid in China.
Feng S; Lin L; Jin P; Wu Q; Zhou W; Sang H; Shao C
Int J Dermatol; 2008 Jan; 47(1):24-8. PubMed ID: 18173596
[TBL] [Abstract][Full Text] [Related]
19. Increased serum levels of B cell activating factor (BAFF) in subsets of patients with idiopathic inflammatory myopathies.
Krystufková O; Vallerskog T; Helmers SB; Mann H; Putová I; Belácek J; Malmström V; Trollmo C; Vencovsky J; Lundberg IE
Ann Rheum Dis; 2009 Jun; 68(6):836-43. PubMed ID: 18628284
[TBL] [Abstract][Full Text] [Related]
20. BAFF and APRIL expression in B-cell chronic lymphocytic leukemia: correlation with biological and clinical features.
Bojarska-Junak A; Hus I; Chocholska S; Wasik-Szczepanek E; Sieklucka M; Dmoszyńska A; Roliński J
Leuk Res; 2009 Oct; 33(10):1319-27. PubMed ID: 19395025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
